The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
about
The Wearable Cardioverter/Defibrillator - Toy Or Tool?Improving the appropriateness of sudden arrhythmic death primary prevention by implantable cardioverter-defibrillator therapy in patients with low left ventricular ejection fraction. Point of view2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of theAdvocacy for outpatient cardiac rehabilitation globally.Cost-effectiveness of primary prevention implantable cardioverter defibrillator treatment: data from a large clinical registry.Economic evaluations of implantable cardioverter defibrillators: a systematic review.Follow-up of implantable cardioverter-defibrillator therapy: comparison of coronary artery disease and dilated cardiomyopathy.Short term cost effectiveness of a regional myocardial infarction network.Implementation of guidelines for implantable cardioverter-defibrillator therapy in clinical practice: Which patients do benefit?The cost effectiveness of implantable cardioverter defibrillators: a systematic review of economic evaluations.Dutch outcome in implantable cardioverter-defibrillator therapy (DO-IT): registry design and baseline characteristics of a prospective observational cohort study to predict appropriate indication for implantable cardioverter-defibrillatorPrimary prevention implantable cardioverter defibrillator in patients with non-ischaemic cardiomyopathy: a meta-analysis of randomised controlled trials.Improving the Methods for the Economic Evaluation of Medical Devices.Who benefits from implantable cardioverter defibrillator therapy, and who pays the price?Identifying patients with less potential to benefit from implantable cardioverter-defibrillator therapy: comparison of the performance of four risk scoring systems.Cost-effectiveness of heart failure therapies.Prevention of sudden death in adolescent athletes: Incremental diagnostic value and cost-effectiveness of diagnostic tests.Evaluation of the need of elective implantable cardioverter-defibrillator generator replacement in primary prevention patients without prior appropriate ICD therapy.Brugada syndrome and the story of Dave.
P2860
Q28077810-1C6183C8-16A8-492E-A4C4-042A8141BCB8Q28079620-3A6AC66C-7D6B-4407-830C-5759178F1745Q28087002-20FEE045-A1E9-4655-9792-C141FEF45C3DQ30381867-511AC1F9-BC35-486B-9F7F-0095A35B293BQ30664657-14681F5B-730E-472C-9CDE-EC91A6C11955Q33164873-5FD5D6CF-F704-4156-9AAD-2132D8C97187Q34302789-E697DE86-9EB5-416F-AE31-31122D37B699Q36769564-5572F58F-CDC8-4597-A1E7-6D16AFC295E0Q36868452-ADE0ABAC-7455-4631-934A-CBE6207BD19BQ38163484-E7A9D422-4891-4866-AD59-B4929EB3446EQ38635591-6FA343A1-EFA9-436E-B13B-2236F84864FBQ38668314-43492588-0CE1-49E9-92AC-D3C6261007BDQ39110914-6295D1BF-C4CE-418D-8D98-FACBBF2B5BE1Q40953694-D9CC5A7E-4DF8-4541-8E5B-5D222E013052Q41051372-EBA0B89F-5121-4DE0-8301-9CDA64643672Q45897479-95FA2153-2259-4B77-A5DA-DB47F0F7FD29Q47339260-CDCF62FA-0922-4EB7-B9E9-7D5A98DBF7CBQ48293650-6EF853A0-0895-4CDC-8C2A-A4EF54AFD448Q52095799-069004DF-5F69-4F96-9CB9-04E595CEB81D
P2860
The cost-effectiveness of primary prophylactic implantable defibrillator therapy in patients with ischaemic or non-ischaemic heart disease: a European analysis
description
2013 nî lūn-bûn
@nan
2013 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
The cost-effectiveness of prim ...... t disease: a European analysis
@ast
The cost-effectiveness of prim ...... t disease: a European analysis
@en
The cost-effectiveness of prim ...... t disease: a European analysis
@nl
type
label
The cost-effectiveness of prim ...... t disease: a European analysis
@ast
The cost-effectiveness of prim ...... t disease: a European analysis
@en
The cost-effectiveness of prim ...... t disease: a European analysis
@nl
prefLabel
The cost-effectiveness of prim ...... t disease: a European analysis
@ast
The cost-effectiveness of prim ...... t disease: a European analysis
@en
The cost-effectiveness of prim ...... t disease: a European analysis
@nl
P2093
P2860
P3181
P356
P1476
The cost-effectiveness of prim ...... t disease: a European analysis
@en
P2093
A. A. Wilde
D. A. M. J. Theuns
L. Jordaens
M. G. M. Hunink
P. F. van Dessel
P2860
P3181
P356
10.1093/EURHEARTJ/EHS090
P407
P577
2013-01-01T00:00:00Z